ArticleClinical parkinsonism & related disorders2026
Chorea-predominant SCA5 mimicking Huntington's disease: A case report with a novel
Article in Clinical parkinsonism & related disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chorea has diverse etiologies, with Huntington's disease (HD) being the most common genetic cause. While spinocerebellar ataxias (SCAs) rarely present with chorea, SCA5 is typically regarded as a "pure" cerebellar syndrome. To our knowledge, chorea has not been previously reported as the predominant manifestation of SCA5. Case presentation: A 51-year-old male presented with progressive dysarthria and generalized chorea. Family history suggested autosomal dominant inheritance. Cranial MRI revealed cerebellar atrophy and frontal-horn enlargement. Initially misdiagnosed with HD, he received olanzapine, achieving partial relief. Whole-exome sequencing (WES) subsequently identified a novel heterozygous missense variant in Conclusion: This case demonstrates that
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.